Michael O. Daines, MD

home / authors / michael-o-daines-md

Michael O. Daines, MD, division chief, Pediatric Allergy and Immunology, University of Arizona College of Medicine; Principal investigator, phase 3 study of Panzyga for PANS.

Articles

Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD

Michael O. Daines, MD

June 19th 2025

In this video interview, Michael Daines, MD, explains phase 3 data for Panzyga (Octapharma) for pediatric acute- onset neuropsychiatric syndrome (PANS).

Michael Daines, MD, discusses pediatric acute-onset neuropsychiatric syndrome

Michael O. Daines, MD

June 12th 2025

Michael O. Daines, MD, outlines key diagnostic criteria and treatment challenges for pediatric acute-onset neuropsychiatric syndrome (PANS), emphasizing the need for multidisciplinary care and improved treatment access.